Spotlight Asset Group’s Novartis NVS Stock Holding History

Spotlight Asset Group’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$112K	Hold	1,055	–	–	0.08%	97
2024 Q1	$102K	Buy	1,055 +54	+5%	+$5.54K	0.07%	108
2023 Q4	$102K	Hold	1,001	–	–	0.09%	94
2023 Q3	$102K	Hold	1,001	–	–	0.09%	94
2023 Q2	$101K	Buy	+1,001	New	+$100K	0.09%	97
2021 Q3	$268K	Sell	3,275 -390	-11%	-$35.1K	0.13%	97
2021 Q2	$334K	Sell	3,665 -94	-3%	-$8.37K	0.13%	95
2021 Q1	$321K	Sell	3,759 -1,297	-26%	-$116K	0.12%	97
2020 Q4	$477K	Buy	5,056 +245	+5%	+$21.4K	0.18%	79
2020 Q3	$418K	Sell	4,811 -506	-10%	-$43.8K	0.16%	89
2020 Q2	$464K	Sell	5,317 -288	-5%	-$24.9K	0.19%	78
2020 Q1	$462K	Sell	5,605 -5	-0.1%	-$446	0.25%	67
2019 Q4	$476K	Buy	+5,610	New	+$503K	0.23%	68

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

CCM

Cullen Capital Management New York $9.75B AUM 21.81% 1-Year Est. Return

Spotlight Asset Group's NVS Position: Q2 2024 in Review

Spotlight Asset Group held its Novartis (NVS) position steady in Q2 2024 at 1,055 shares worth $112K. The position accounts for 0.08% of the portfolio, ranked #97.

Spotlight Asset Group first reported a position in NVS in Q4 2019 and has held it in 13 quarters since. The position peaked at $477K in Q4 2020. 1,307 funds tracked by Wall St. Rank hold NVS as of Q2 2024.

Spotlight Asset Group held 1,055 shares of Novartis worth $112K as of Q2 2024.
Spotlight Asset Group left its Novartis share count unchanged in Q2 2024.
Novartis made up 0.08% of Spotlight Asset Group's portfolio in Q2 2024, its #97 holding.
Spotlight Asset Group first reported a position in Novartis in Q4 2019 and has held it in 13 quarters since.
Spotlight Asset Group's Novartis position peaked at $477K in Q4 2020.
1,307 funds tracked by Wall St. Rank held Novartis as of Q2 2024.

Based on Spotlight Asset Group's 13F filing for Q2 2024, filed 24 Jul 2024.